Kate Weiss

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Cristina Valero, Mark Lee, Douglas R. Hoen et al. · Nature Communications · 2021 · 456 citations · Full text

Life Sciences, Immunology, Oncology +17

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Diego Chowell, Seong‐Keun Yoo, Cristina Valero et al. · Nature Biotechnology · 2021 · 270 citations · Full text

Life Sciences, Immunology, Oncology +14

Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies

Emily R. Kansler, Saïda Dadi, Chirag Krishna et al. · Nature Immunology · 2022 · 119 citations · Full text

Life Sciences, Immunology, Oncology +12

The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management

Stanley Weng, Renzo G. DiNatale, Andrew W. Silagy et al. · European Urology · 2020 · 47 citations · Full text

Medicine, Oncology, Pathology +12

High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Chung‐Han Lee, Renzo G. DiNatale, Diego Chowell et al. · Molecular Cancer Research · 2021 · 33 citations · Full text

Medicine, Immunology, Oncology +17